Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
CN Stock MarketDetailed Quotes
603379 Zhejiang Sanmei Chemical Industry
- 33.54
- +1.18+3.65%
Not Open Dec 18 15:00 CST
20.48BMarket Cap33.98P/E (TTM)
33.98High32.67Low55.30KlotVolume32.74Open32.36Pre Close184.61MTurnover0.91%Turnover Ratio73.23P/E (Static)610.48MShares46.9252wk High3.29P/B20.48BFloat Cap25.8052wk Low35.60Limit Up610.48MShs Float47.72Historical High29.12Limit Down4.05%Amplitude14.17Historical Low0.23Dividend TTM33.38Avg Price20.11KlotAsk0.69%Div YieldTTM100Lot Size31.88KlotBid
Zhejiang Sanmei Chemical Industry Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 16.50%3.04B | 17.51%2.04B | 23.28%958.61M | -30.12%3.33B | -30.76%2.61B | -32.41%1.74B | -34.12%777.6M | 17.84%4.77B | 37.58%3.77B | 45.29%2.57B |
| Operating revenue | 16.50%3.04B | 17.51%2.04B | 23.28%958.61M | -30.12%3.33B | -30.76%2.61B | -32.41%1.74B | -34.12%777.6M | 17.84%4.77B | 37.58%3.77B | 45.29%2.57B |
| Other operating revenue | ---- | -68.08%34M | ---- | -49.39%68.13M | ---- | 19.55%106.5M | ---- | -23.57%134.63M | ---- | 2.92%89.09M |
| Total operating cost | 1.87%2.34B | -0.34%1.57B | 2.98%774.75M | -26.12%3.05B | -27.44%2.3B | -24.61%1.58B | -20.29%752.33M | 23.75%4.13B | 32.17%3.17B | 34.80%2.09B |
| Operating cost | -4.59%2.18B | -2.18%1.49B | 5.95%740.32M | -27.90%2.89B | -26.57%2.28B | -24.91%1.52B | -21.29%698.75M | 28.74%4B | 38.10%3.11B | 39.68%2.03B |
| Operating tax surcharges | 19.50%16.64M | 33.88%11.6M | 16.86%4.52M | -8.03%19.76M | -19.26%13.92M | -28.15%8.66M | -44.56%3.87M | 81.49%21.48M | 145.08%17.24M | 224.15%12.06M |
| Operating expense | -11.96%37.21M | -19.45%23.25M | -29.19%9.83M | -13.93%55.66M | -13.36%42.27M | -18.01%28.86M | -13.21%13.89M | 5.15%64.66M | 18.85%48.78M | 26.90%35.2M |
| Administration expense | 7.96%119.34M | -2.85%72.09M | -2.34%35.94M | -2.22%162.68M | -3.39%110.54M | 1.38%74.2M | 4.53%36.8M | 30.90%166.38M | 34.80%114.42M | 35.49%73.19M |
| Financial expense | 63.70%-66.75M | 19.67%-63.38M | -219.69%-31.3M | 23.12%-123.95M | -23.85%-183.86M | -1.75%-78.9M | -14.65%-9.79M | -5,683.05%-161.23M | -1,843.15%-148.45M | -4,484.28%-77.55M |
| -Interest expense (Financial expense) | -0.34%123.3K | -16.58%84.08K | ---- | -46.84%166.88K | -49.53%123.73K | -39.23%100.79K | ---- | 7.49%313.92K | 59.27%245.18K | 25.23%165.84K |
| -Interest Income (Financial expense) | 59.28%-66.24M | 3.48%-52.77M | -49.01%-26.79M | -57.01%-111.42M | -231.43%-162.66M | -115.35%-54.68M | -121.76%-17.98M | -217.77%-70.96M | -162.51%-49.08M | -73.49%-25.39M |
| Research and development | 75.09%56.8M | 94.63%35.49M | 75.15%15.44M | 38.49%53.06M | 23.28%32.44M | 7.76%18.23M | 35.92%8.82M | 42.82%38.31M | 31.87%26.31M | 28.24%16.92M |
| Credit Impairment Loss | -128.10%-3.33M | -123.03%-2.04M | -152.34%-3.43M | -10.22%16.46M | 1,680.93%11.84M | 200.86%8.86M | -48.55%6.55M | 157.59%18.33M | 96.30%-748.85K | 59.26%-8.78M |
| Asset Impairment Loss | ---- | -45.76%-444.93K | ---- | 100.54%204.24K | 39.23%-9.06M | 99.27%-305.25K | 87.09%-1.45M | -20.90%-37.76M | ---14.91M | ---42.05M |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | --0.01 | ---- | --0.01 | ---- | ---- | ---- |
| Other net revenue | 72.40%14.41M | -1.17%15.13M | -89.50%539.31K | 79.01%18.99M | -50.02%8.36M | 178.65%15.31M | -74.46%5.13M | 126.29%10.61M | -43.08%16.72M | -282.30%-19.47M |
| Fair value change income | 131.29%2.95M | 72.79%1.47M | -64.19%160.82K | -87.62%1.74M | -91.31%1.28M | -94.63%849.1K | -96.69%449.13K | -76.01%14.02M | -63.74%14.68M | -38.13%15.8M |
| Invest income | -59.47%-9.42M | 205.20%2.71M | 238.12%2.57M | -714.57%-12.86M | -351.98%-5.91M | -265.17%-2.57M | -171.55%-1.86M | -54.45%-1.58M | 61.83%2.34M | 223.40%1.56M |
| -Including: Investment income associates | -211.24%-19.02M | 195.46%2.64M | 227.11%2.57M | -303.16%-13.09M | -1,267.82%-6.11M | -670.08%-2.77M | -241.50%-2.02M | 59.54%-3.25M | 115.24%523.33K | 127.18%485.48K |
| Asset deal income | 177.62%4.49M | 230.23%4.49M | -59.49%74.13K | 7,380.30%1.95M | 456.92%1.62M | 1,629.88%1.36M | --183K | -93.43%26.01K | -216.41%-452.99K | -147.03%-88.85K |
| Other revenue | 129.42%19.71M | 25.69%8.96M | -9.06%1.16M | -34.51%11.5M | -45.65%8.59M | -49.44%7.12M | -48.68%1.27M | 76.90%17.57M | 116.43%15.81M | 133.69%14.09M |
| Operating profit | 124.12%710.63M | 175.77%485.1M | 506.31%184.4M | -53.87%298.67M | -48.42%317.07M | -61.70%175.91M | -88.15%30.41M | -9.17%647.47M | 66.32%614.69M | 101.19%459.26M |
| Add:Non operating Income | -55.27%773.33K | -31.74%680.8K | 31.32%418.87K | 2,309.20%85.74M | 6.89%1.73M | 14.08%997.36K | -2.64%318.98K | -89.53%3.56M | 17.50%1.62M | -12.51%874.24K |
| Less:Non operating expense | -39.57%3.98M | -48.10%2.79M | -66.59%1.54M | 15.31%8.98M | 67.01%6.58M | 66.29%5.37M | 131.26%4.62M | -82.07%7.79M | -90.39%3.94M | -91.86%3.23M |
| Total profit | 126.58%707.42M | 181.57%482.99M | 601.97%183.27M | -41.64%375.43M | -49.01%312.22M | -62.46%171.53M | -89.76%26.11M | -8.55%643.24M | 85.61%612.36M | 140.97%456.91M |
| Less:Income tax cost | 99.91%148.3M | 137.36%99.29M | 372.28%28.98M | -39.25%95.78M | -50.75%74.18M | -62.94%41.83M | -90.10%6.14M | -5.70%157.67M | 73.26%150.63M | 134.61%112.89M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Net profit | 134.89%559.12M | 195.83%383.7M | 672.53%154.29M | -42.41%279.64M | -48.45%238.03M | -62.30%129.7M | -89.65%19.97M | -9.44%485.57M | 90.03%461.73M | 143.14%344.02M |
| Net profit from continuing operation | 134.89%559.12M | 195.83%383.7M | 672.53%154.29M | -42.41%279.64M | -48.45%238.03M | -62.30%129.7M | -89.65%19.97M | -9.44%485.57M | 90.03%461.73M | 143.14%344.02M |
| Less:Minority Profit | ---1.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit of parent company owners | 135.63%560.87M | 195.83%383.7M | 672.53%154.29M | -42.41%279.64M | -48.45%238.03M | -62.30%129.7M | -89.65%19.97M | -9.44%485.57M | 90.03%461.73M | 143.14%344.02M |
| Earning per share | ||||||||||
| Basic earning per share | 135.90%0.92 | 200.00%0.63 | 733.33%0.25 | -42.50%0.46 | -48.68%0.39 | -63.16%0.21 | -90.63%0.03 | -9.09%0.8 | 90.00%0.76 | 147.83%0.57 |
| Diluted earning per share | 135.90%0.92 | 200.00%0.63 | 733.33%0.25 | -42.50%0.46 | -48.68%0.39 | -63.16%0.21 | -90.63%0.03 | -9.09%0.8 | 90.00%0.76 | 147.83%0.57 |
| Other composite income | 347.26%5.69K | -671.44%-8.06K | -6,566.59%-7.39K | -93.50%521.38 | 15.69%-2.3K | 415.23%1.41K | 87.31%-110.88 | 141.90%8.02K | 86.35%-2.73K | 96.23%-447.62 |
| Other composite income of parent company owners | 347.26%5.69K | -671.44%-8.06K | -6,566.59%-7.39K | -93.50%521.38 | 15.69%-2.3K | 415.23%1.41K | 87.31%-110.88 | 141.90%8.02K | 86.35%-2.73K | 96.23%-447.62 |
| Total composite income | 134.90%559.13M | 195.82%383.69M | 672.50%154.28M | -42.41%279.65M | -48.45%238.03M | -62.30%129.7M | -89.65%19.97M | -9.43%485.58M | 90.04%461.73M | 143.16%344.02M |
| Total composite income of parent company owners | 135.63%560.88M | 195.82%383.69M | 672.50%154.28M | -42.41%279.65M | -48.45%238.03M | -62.30%129.7M | -89.65%19.97M | -9.43%485.58M | 90.04%461.73M | 143.16%344.02M |
| Total composite income of minority owners | ---1.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
